Enhancer ID: | E_02_0534 |
Species: | human |
Position : | chr19:33297216-33299216 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Acute myeloid leukemia |
Pubmed ID: | 30002127 |
Enhancer experiment: | Western blot, real time PCR, statistical analysis |
Enhancer experiment description: | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
Target gene : | CEBPA(C/ebpalpha,CBF-A,Cebp) |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
TF name : | -- |
TF experiment: | Western blot,Real-Time PCR,???? |
TF experiment description: | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
Enhancer function : | Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
Lack of, aberrant or suboptimal C/EBP? activity can result from genomic mutations in the CEBPA gene,8 transcriptional suppression originating from promoter hypermethylation, or functional inactivation by phosphorylation. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|